# IBD Pregnancy Registry

> **NCT06910553** · — · RECRUITING · sponsor: **CorEvitas** · enrollment: 832 (estimated)

## Conditions studied

- Inflammatory Bowel Disease (IBD)

## Interventions

- **OTHER:** Non-exposed group
- **DRUG:** Exposed to IBD pharmacotherapy during pregnancy

## Key facts

- **NCT ID:** NCT06910553
- **Lead sponsor:** CorEvitas
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2032-09
- **Final completion:** 2032-09
- **Target enrollment:** 832 (ESTIMATED)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06910553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06910553, "IBD Pregnancy Registry". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06910553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*